about
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States a...
Read More
7.44
-0.07
(-0.93%)
740.2K
XNAS Volume
XNAS 07 Aug, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for CorMedix Inc is on 13 Aug 2026 for the purpose of Cormedix Inc Second Quarter Earnings Result for 2026
See details
Medium Financial Strength
Affordable Valuation
Technically Bearish
Falling Comet
These stocks are medium quality with average financials. However, their weak momentum indicates low investor interest
View Similar
Embed DVM
CorMedix Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..